United Health Products, Inc. ( OTCQB: UEEC), a developer and marketer of wound care products and technologies in the healthcare sector, announced that Douglas Beplate will present at the Sixth Annual LD MICRO Conference on Tuesday, December 3 rd, at 1:00 p.m. PST, at the Luxe Hotel Sunset Boulevard in Los Angeles. Beplate will discuss the Company’s outlook and the progress of the commercialization of HemoStyp®, its proprietary gauze product, to its target markets, including the dental and dialysis marketplace. About LD MICRO LD MICRO ( http://www.ldmicro.com) is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor. To learn more, please call 408-457-1042 or visit http://www.ldmicro.com. About United Health Products, Inc. United Health Products, Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp™, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit www.unitedhealthproductsinc.com. Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.